Homozygous hypomorphic HNF1A alleles are a novel cause of young-onset diabetes and result in sulphonylurea sensitive diabetes
<p><strong>OBJECTIVE</strong> Heterozygous loss-of-function mutations in HNF1A cause maturity-onset diabetes of the young (MODY). Affected individuals can be treated with low-dose sulphonylureas. Individuals with homozygous HNF1A mutations causing MODY have not been reported.</p...
Main Authors: | Misra, S, Hassanali, N, Bennett, AJ, Juszczak, A, Caswell, R, Colclough, K, Valabhji, J, Ellard, S, Oliver, NS, Gloyn, AL |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Diabetes Association
2020
|
Similar Items
-
Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
by: Turkkahraman, D, et al.
Published: (2008) -
Maturity onset diabetes of the young due to HNF1A variants in Croatia
by: Pavić, T, et al.
Published: (2018) -
The phenotypic severity of homozygous GCK mutations causing neonatal or adolescent-onset diabetes is mediated through thermostability in addition to enzyme activity
by: Chakera, A, et al.
Published: (2014) -
A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
by: Proks, P, et al.
Published: (2006) -
Assessment and translation of novel biomarkers for diagnosis of maturity onset diabetes of the young due to HNF1A variants
by: Juszczak, A
Published: (2018)